Literature DB >> 33400709

Self-reported challenges to border screening of travelers for Ebola by district health workers in northern Ghana: An observational study.

John Koku Awoonor-Williams1, Cheryl A Moyer2, Martin Nyaaba Adokiya3.   

Abstract

BACKGROUND: The 2013-2016 Ebola Virus Disease (EVD) outbreak remains the largest on record, resulting in the highest mortality and widest geographic spread experienced in Africa. Ghana, like many other African nations, began screening travelers at all entry points into the country to enhance disease surveillance and response. This study aimed to assess the challenges of screening travelers for EVD at border entry in northern Ghana. DESIGN AND METHODS: This was an observational study using epidemiological weekly reports (Oct 2014-Mar 2015) of travelers entering Ghana in the Upper East Region (UER) and qualitative interviews with 12 key informants (7 port health officers and 5 district directors of health) in the UER. We recorded the number of travelers screened, their country of origin, and the number of suspected EVD cases from paper-based weekly epidemiological reports at the border entry. We collected qualitative data using an interview guide with a particular focus on the core and support functions (e.g. detection, reporting, feedback, etc.) of the World Health Organization's Integrated Disease Surveillance and Response system. Quantitative data was analyzed based on travelers screened and disaggregated by the three most affected countries. We used inductive approach to analyze the qualitative data and produced themes on knowledge and challenges of EVD screening.
RESULTS: A total of 41,633 travelers were screened, and only 1 was detained as a suspected case of EVD. This potential case was eventually ruled out via blood test. All but 52 of the screened travelers were from Ghana and its contiguous neighbors, Burkina Faso and Togo. The remaining 52 were from the four countries most affected by EVD (Guinea, Liberia, Sierra Leone, and Mali). Challenges to effective border screening included: inadequate personal protective equipment and supplies, insufficient space or isolation rooms and delays at the border crossings, and too few trained staff. Respondents also cited lack of capacity to confirm cases locally, lack of cooperation by some travelers, language barriers, and multiple entry points along porous borders. Nonetheless, no potential Ebola case identified through border screening was confirmed in Ghana.
CONCLUSION: Screening for Ebola remains sub-optimal at the entry points in northern Ghana due to several systemic and structural factors. Given the likelihood of future infectious disease outbreaks, additional attention and support are required if Ghana is to minimize the risk of travel-related spread of illness.

Entities:  

Year:  2021        PMID: 33400709      PMCID: PMC7785234          DOI: 10.1371/journal.pone.0245039

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  21 in total

1.  Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact.

Authors:  Varvara A Mouchtouri; Eleni P Christoforidou; Maria An der Heiden; Cinthia Menel Lemos; Margherita Fanos; Ute Rexroth; Ulrike Grote; Evelien Belfroid; Corien Swaan; Christos Hadjichristodoulou
Journal:  Int J Environ Res Public Health       Date:  2019-11-21       Impact factor: 3.390

2.  Ebola: worldwide dissemination risk and response priorities.

Authors:  Benjamin J Cowling; Hongjie Yu
Journal:  Lancet       Date:  2014-10-21       Impact factor: 79.321

3.  Profile of the Navrongo Health and Demographic Surveillance System.

Authors:  Abraham Rexford Oduro; George Wak; Daniel Azongo; Cornelius Debpuur; Peter Wontuo; Felix Kondayire; Paul Welaga; Ayaga Bawah; Alex Nazzar; John Williams; Abraham Hodgson; Fred Binka
Journal:  Int J Epidemiol       Date:  2012-08       Impact factor: 7.196

4.  Structure and performance of infectious disease surveillance and response, United Republic of Tanzania, 1998.

Authors:  Peter Nsubuga; Nicholas Eseko; Wuhib Tadesse; Nestor Ndayimirije; Chungong Stella; Scott McNabb
Journal:  Bull World Health Organ       Date:  2002       Impact factor: 9.408

5.  Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic.

Authors:  C Poletto; M F Gomes; A Pastore y Piontti; L Rossi; L Bioglio; D L Chao; I M Longini; M E Halloran; V Colizza; A Vespignani
Journal:  Euro Surveill       Date:  2014-10-23

Review 6.  Entry screening for infectious diseases in humans.

Authors:  Linda A Selvey; Catarina Antão; Robert Hall
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

7.  Health workers perceptions and attitude about Ghana's preparedness towards preventing, containing, and managing Ebola Virus Disease.

Authors:  Philip Baba Adongo; Philip Teg-Nefaah Tabong; Emmanuel Asampong; Joana Ansong; Magda Robalo; Richard M Adanu
Journal:  BMC Health Serv Res       Date:  2017-04-12       Impact factor: 2.655

8.  'When Ebola enters a home, a family, a community': A qualitative study of population perspectives on Ebola control measures in rural and urban areas of Sierra Leone.

Authors:  Nell Gray; Beverley Stringer; Gina Bark; Andre Heller Perache; Freya Jephcott; Rob Broeder; Ronald Kremer; Augustine S Jimissa; Thomas T Samba
Journal:  PLoS Negl Trop Dis       Date:  2018-06-08

9.  The integrated disease surveillance and response system in northern Ghana: challenges to the core and support functions.

Authors:  Martin N Adokiya; John K Awoonor-Williams; Claudia Beiersmann; Olaf Müller
Journal:  BMC Health Serv Res       Date:  2015-07-28       Impact factor: 2.655

10.  Challenges to Ebola preparedness during an ongoing outbreak: An analysis of borderland livelihoods and trust in Uganda.

Authors:  Megan M Schmidt-Sane; Jannie O Nielsen; Mandi Chikombero; Douglas Lubowa; Miriam Lwanga; Jonathan Gamusi; Richard Kabanda; David Kaawa-Mafigiri
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.